Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia

References

• Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549–53.
   PubMed Web of Science ®Google Scholar
• Robinson RC, Radziejewski C, Stuart DI, Jones EY. Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer. Biochemistry 1995;34:4139–46.
   PubMed Web of Science ®Google Scholar
• Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008;33:73–83.
   PubMed Web of Science ®Google Scholar
• Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007;10:1089–93.
   PubMed Web of Science ®Google Scholar
• Mercader JM, Ribases M, Gratacos M, Gonzalez JR, Bayes M, de Cid R, et al. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav 2007;6:706–16.
   PubMed Web of Science ®Google Scholar
• Klaffke S, Konig IR, Poustka F, Ziegler A, Hebebrand J, Bandmann O. Brain-derived neurotrophic factor: a genetic risk factor for obsessive–compulsive disorder and Tourette syndrome? Mov Disord 2006;21:881–3.
   PubMed Web of Science ®Google Scholar
• Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer’s disease: role of axonal transport. Genes Brain Behav 2008;7(Suppl1):43–56.
   PubMed Web of Science ®Google Scholar
• Toyooka K, Asama K, Watanabe Y, Muratake T, Takahashi M, Someya T, et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 2002;110:249–57.
   PubMed Web of Science ®Google Scholar
• Tan YL, Zhou DF, Cao LY, Zou YZ, Zhang XY. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci Lett 2005;382:27–32.
   PubMed Web of Science ®Google Scholar
• Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S. Brain derived neurotropic factor in first-episode psychosis. Schizophr Res 2007;91:1–5.
   PubMed Web of Science ®Google Scholar
• Rizos EN, Rontos I, Laskos E, Arsenis G, Michalopoulou PG, Vasilopoulos D et al. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1308–11.
   PubMed Web of Science ®Google Scholar
• Jindal RD, Pillai AK, Mahadik SP, Eklund K, Montrose DM, Keshavan MS. Decreased BDNF in patients with antipsychotic naive first episode schizophrenia. Schizophr Res 2010;119:47–51.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Yahata N, Ito I, Nagano M, Toyota T, Yoshikawa T, et al. Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophr Res 2008;101:58–66.
   PubMed Web of Science ®Google Scholar
• Koeva YA, Sivkov ST, Akabaliev VH, Ivanova RY, Deneva TI, Grozlekova LS, et al. Brain-derived neurotrophic factor and its serum levels in schizophrenic patients. Folia Med (Plovdiv) 2014;56:20–23.
   PubMedGoogle Scholar
• Rizos EN, Michalopoulou PG, Siafakas N, Stefanis N, Douzenis A, Rontos I, et al. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia. Neuropsychobiology 2010;62:87–90.
   PubMed Web of Science ®Google Scholar
• Shimizu E, Hashimoto K, Watanabe H, Komatsu N, Okamura N, Koike K, et al. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett 2003;351:111–14.
   PubMed Web of Science ®Google Scholar
• Niitsu T, Ishima T, Yoshida T, Hashimoto T, Matsuzawa D, Shirayama Y, et al. A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia. Psychiatry Res 2014;215:268–73.
   PubMed Web of Science ®Google Scholar
• Renjan V, Nurjono M, Lee J. Serum brain-derived neurotrophic factor (BDNF) and its association with remission status in Chinese patients with schizophrenia. Psychiatry Res 2014;220:193–6.
   PubMed Web of Science ®Google Scholar
• Kalmady SV, Venkatasubramanian G, Shivakumar V, Jose D, Ravi V, Gangadhar BN. Relationship between brain-derived neurotrophic factor and schneiderian first rank symptoms in antipsychotic-naive schizophrenia. Front Psychiatry 2013;4:64.
   PubMedGoogle Scholar
• Jones KR, Reichardt LF. Molecular cloning of a human gene that is a member of the nerve growth factor family. Proc Natl Acad Sci USA 1990;87:8060–4.
   PubMed Web of Science ®Google Scholar
• Ma L, Harada T, Harada C, Romero M, Hebert JM, McConnell SK, et al. Neurotrophin-3 is required for appropriate establishment of thalamocortical connections. Neuron 2002;36:623–34.
   PubMed Web of Science ®Google Scholar
• Durany N, Michel T, Zochling R, Boissl KW, Cruz-Sanchez FF, Riederer P, et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 2001;52:79–86.
   PubMed Web of Science ®Google Scholar
• Vargas HE, Gama CS, Andreazza AC, Medeiros D, Stertz L, Fries G, et al. Decreased serum neurotrophin 3 in chronically medicated schizophrenic males. Neurosci Lett 2008;440:197–201.
   PubMed Web of Science ®Google Scholar
• Gilmore JH, Jarskog LF, Lindgren JC, McEvoy JP, Xiao H. Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness. Psychiatry Res 1997;73:109–13.
   PubMed Web of Science ®Google Scholar
• Hock C, Heese K, Muller-Spahn F, Huber P, Riesen W, Nitsch RM, et al. Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Mol Psychiatry 2000;5:510–13.
   PubMed Web of Science ®Google Scholar
• Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Cereser KM, Cunha AB, et al. Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett 2007;415:87–9.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Gama CS, Walz JC, Cereser KM, Fries GR, Colpo G, et al. Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes. J Psychiatr Res 2010;44:561–5.
   PubMed Web of Science ®Google Scholar
• Otsuki K, Uchida S, Watanuki T, Wakabayashi Y, Fujimoto M, Matsubara T, et al. Altered expression of neurotrophic factors in patients with major depression. J Psychiatr Res 2008;42:1145–53.
   PubMed Web of Science ®Google Scholar
• Munkholm K, Pedersen BK, Kessing LV, Vinberg M. Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients. Psychoneuroendocrinology 2014;47:199–211.
   PubMed Web of Science ®Google Scholar
• Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res 1990;3:247–51.
   PubMed Web of Science ®Google Scholar
• Pae CU, Marks DM, Han C, Patkar AA, Steffens D. Does neurotropin-3 have a therapeutic implication in major depression? Int J Neurosci 2008;118:1515–22.
   PubMed Web of Science ®Google Scholar
• Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005;26:115–23.
   PubMed Web of Science ®Google Scholar
• Civelek S, Konukoglu D, Erdenen F, Uzun H. Serum neurotrophic factor levels in patients with type 2 diabetes mellitus: relationship to metabolic syndrome components. Clin Lab 2013;59:369–74.
   PubMed Web of Science ®Google Scholar